Tag: Sleep Therapy
Sunrise accelerates U.S. expansion
December 16, 2024HME News Staff
NAMUR, Belgium – Sunrise, a sleep disorder diagnostics company, has acquired Dreem Health, a California-based sleep clinic that offers diagnosis and treatment options, in a move that expands its presence in the U.S. Sunrise says millions of people across California, Iowa, Maryland, Washington and more can now access its sleep diagnostic and care devices through Dreem Health. “As we build out our U.S. presence, Sunrise is set to innovate the global sleep health market,” said Laurent...
HoneyNaps is official in US
October 8, 2024HME News Staff
BOSTON – HoneyNaps, which is based in South Korea, has delivered its artificial intelligence sleep disorder diagnostic software SOMNUM to two medical institutions in the United States, it announced Oct. 7. "The U.S. is the largest sleep medicine market in the world and still holds significant growth potential,” a company representative said. “As we officially enter the U.S. market, we will solidify our business strategy to achieve a 10% market share within three years."...
EnsoData, partners connect dots
June 7, 2024Liz Beaulieu, Editor
MADISON, Wis. – EnsoData now has strategic partnerships with React Health, a CPAP manufacturer; Parachute Health, an e-prescribing vendor; and Aeroflow Health, a CPAP provider. It’s all part of the company’s mission to connect the dots from diagnostics to therapy, says Sam Rusk, co-founder and chief artificial intelligence officer.
Here’s what Rusk had to say about EnsoData’s partnership with Aeroflow Health and how it’s excited to empower providers...
Survey finds improving supply for CPAP devices
March 18, 2024HME News Staff
NEW YORK – Respondents saw a 6% increase in sleep patient volume, on average, in the last 12 months, according to the HME Sleep and Oxygen Survey for the first quarter of 2024 from Needham and Co.
Respondents expect 6.5% growth in the next 12 months.
“We suspect that the increase is due to improving flow generator supply and HMEs engaging both new and backlogged patients that resulted from the Philips Respironics recall,” the report stated.
Other...
OM highlights diabetes, downplays weight loss drugs
November 8, 2023Theresa Flaherty, Managing Editor
RICHMOND, Va. – Owens & Minor officials are excited about the future of the Patient Direct segment after posting double-digit growth for the diabetes and sleep categories in the third quarter.
The segment, which reported revenue of $648 million in the quarter, now makes up about 25% of overall revenue.
“(Diabetes and sleep) continue to be extremely strong for us,” said Edward Pesicka, president and CEO, during a recent earnings call. “And you think about...
Nyxoah, ResMed partner in Germany to accelerate sleep therapy
October 2, 2023HME News Staff
MOUNT SAINT GUIBERT, Belgium – Nyxoah, a med tech company focused on the development and commercialization of innovative solutions to treat obstructive sleep apnea, has announced a partnership with ResMed Germany to increase awareness and therapy penetration in the German market.
The companies will establish a continuum of care that will educate and guide OSA patients in the German market from diagnosis through treatment.
"It is our joint goal to enable more patients to receive...
Inspire names former Medtronic exec as chief strategy officer
July 24, 2023HME News Staff
MINNEAPOLIS – Inspire Medical Systems, the maker of an FDA-approved neurostimulation device to treat obstructive sleep apnea, has appointed Carlton Weatherby as chief strategy officer effective July 24. “We are very excited to welcome Carlton to the Inspire team,” said Tim Herbert, president and CEO of Inspire Medical Systems. “Carlton’s vast experience in leadership roles across medtech, as well as his strategic vision, will be very valuable to us as we continue to...
New sleep leader targets reimbursement, data privacy
October 21, 2022Liz Beaulieu, Editor
SAN DIEGO – As Lucile Blaise takes on a larger role at ResMed, she is prioritizing, among other things, advocating for new forms of reimbursement for digital health.
Here’s what Blaise, who was promoted from ResMed’s vice president of Sleep & Respiratory Care for Western Europe to president of its global business this summer, had to say about why everyone wins when sleep apnea is diagnosed and treated.
HME News: CEO Mick Farrell often talks about the...
SleepRes introduces V̇-Com
June 6, 2022HME News Staff
NASHVILLE, Tenn. – SleepRes has entered the sleep therapy market with V̇-Com, a device that softens peak inspiratory flow to make CPAP devices more comfortable and increase adherence. “This may be the most important comfort factor in the PAP circuit since we developed BiPAP over 30 years ago,” said Eugene Scarberry, retired senior staff engineer at Philips Respironics for 35 years. “At the end of the day it is all about adherence and the V̇-Com is a whole new approach to...
ResMed: ‘Our third-quarter results reflect strong performance’
April 28, 2022HME News Staff
SAN DIEGO – ResMed reported revenue increased 12% to $864.5 million in its third quarter fiscal year 2022.
The company reported revenue, excluding software-as-a-service, increased 18% in the United States, Canada and Latin America, primarily due to a recall by one of its competitors and a recovery of core sleep patient flow that has been impacted by the COVID-19 pandemic.
“Our third-quarter results reflect strong performance across our business, resulting in double-digit top-line...